Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-26-022628

Chief Operating Officer gave up 2,309 shares (to pay taxes)

  • Chief Operating Officer acquired 5,254 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Cittadine Andrew · Chief Operating Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-06-30 Exercise or conversion : show line 1 in the form +5,254 57,923 D
2026-06-30 Shares withheld for taxes : show line 2 in the form −2,309 $92.59 $213,790 55,614 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-30 Exercise or conversion : show line 3 in the form Restricted Stock Unit −5,254 39,499 D
Loading xslF345X06/rdgdoc.xml…